11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with Atherogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amamoto, T; Aramaki, H; Eyanagi, R; Imoto, M; Jiang, R; Takeda, S; Toda, A; Watanabe, K; Yamamoto, I | 1 |
1 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and Atherogenesis
| Article | Year |
|---|---|
Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors.
Topics: Arachidonate 15-Lipoxygenase; Atherosclerosis; Dronabinol; Humans; Lipoxygenase Inhibitors; Molecular Targeted Therapy; Receptor, Cannabinoid, CB2 | 2011 |